A prospective, double blind, randomised, multicentre trial to evaluate the efficacy of combination therapy, which comprised imidafenacin and an alpha-blocker, with monotherapy, which comprised an alpha-blocker, at managing men with lower urinary tract symptoms (LUTS) and storage symptoms

Trial Profile

A prospective, double blind, randomised, multicentre trial to evaluate the efficacy of combination therapy, which comprised imidafenacin and an alpha-blocker, with monotherapy, which comprised an alpha-blocker, at managing men with lower urinary tract symptoms (LUTS) and storage symptoms

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2017

At a glance

  • Drugs Alfuzosin (Primary) ; Imidafenacin (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top